EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $235,000 | -14.9% | 5,400 | -1.8% | 0.01% | -14.3% |
Q1 2022 | $276,000 | -1.4% | 5,500 | 0.0% | 0.01% | +16.7% |
Q4 2021 | $280,000 | -10.3% | 5,500 | -1.8% | 0.01% | -25.0% |
Q3 2021 | $312,000 | +37.4% | 5,600 | +5.7% | 0.01% | +33.3% |
Q2 2021 | $227,000 | +2.7% | 5,300 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $221,000 | -10.5% | 5,300 | 0.0% | 0.01% | -14.3% |
Q4 2020 | $247,000 | +3.8% | 5,300 | -5.4% | 0.01% | -36.4% |
Q3 2020 | $238,000 | +15.5% | 5,600 | +63.3% | 0.01% | +10.0% |
Q4 2019 | $206,000 | -1.4% | 3,430 | -7.3% | 0.01% | -9.1% |
Q3 2019 | $209,000 | +1.5% | 3,700 | -2.6% | 0.01% | +10.0% |
Q2 2019 | $206,000 | -39.4% | 3,800 | -22.4% | 0.01% | -33.3% |
Q3 2018 | $340,000 | +21.4% | 4,900 | +32.4% | 0.02% | +15.4% |
Q2 2018 | $280,000 | +34.0% | 3,700 | +5.7% | 0.01% | +30.0% |
Q3 2017 | $209,000 | -17.1% | 3,500 | +9.4% | 0.01% | -16.7% |
Q2 2017 | $252,000 | -8.0% | 3,200 | -3.0% | 0.01% | -14.3% |
Q1 2017 | $274,000 | +7.9% | 3,300 | +3.1% | 0.01% | +7.7% |
Q4 2016 | $254,000 | +3.7% | 3,200 | -8.6% | 0.01% | 0.0% |
Q3 2016 | $245,000 | – | 3,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |